Record entry · Precision Medicine
Nccn
Why this name is on the record
Nothing here was hand-picked. Nccn crossed the platform’s evidence bars on its own counts: 20 mentions across 11 sources over 15 days of tracked coverage · 35% of that coverage sits in a single domain. Those are the numbers that promoted it, kept on the row.
“NCCN introduces first-ever evidence-based guidelines for pediatric bone sarcoma”
“NCCN Models How to Tailor Cancer Care for Different Regions During 2026 World Cancer Congress”
“Mapping tumor heterogeneity: ex-vivo drug responses in matched primary and metastatic tumors using a 3D functional precision platform”
“NCCN Releases New Guideline for Patients and Caregivers: Older Adults With Cancer”
“The 2026 ASCO Annual Meeting Geriatric Oncology Update: The Next Challenge Is Implementation”
GET record row · published ontology entry "nccn"
{
"slug": "nccn",
"label": "Nccn",
"category": "precision_medicine",
"promotedAt": "2026-10-04",
"evidence": {
"mentions": 20,
"sources": 11,
"days": 15,
"concentration": 0.35,
"standAloneShare": 0.8
},
"whereFrom": {
"level": "evidence bars",
"label": "20 mentions · 11 sources · 15 days",
"children": [
{
"level": "reports",
"label": "5 reports from the coverage window",
"children": {
"count": 5,
"unfold": "expand=+1"
}
},
{
"level": "promotion",
"label": "The counts themselves",
"edge": "measured by the ontology promotion pass on 2026-10-04 and kept on the published record row; no human approved them"
}
]
}
}Real: the published record row this page is built from, with its where-from tree folded below the first level.
The coverage behind it
- 2 Oct 2026
The Medical News
NCCN introduces first-ever evidence-based guidelines for pediatric bone sarcoma
“NCCN introduces first-ever evidence-based guidelines for pediatric bone sarcoma”
- 1 Oct 2026
The ASCO Post
NCCN Models How to Tailor Cancer Care for Different Regions During 2026 World Cancer Congress
“NCCN Models How to Tailor Cancer Care for Different Regions During 2026 World Cancer Congress”
- 29 Sept 2026
medRxiv Oncology
Mapping tumor heterogeneity: ex-vivo drug responses in matched primary and metastatic tumors using a 3D functional precision platform
“Mapping tumor heterogeneity: ex-vivo drug responses in matched primary and metastatic tumors using a 3D functional precision platform”
- 17 Sept 2026
The ASCO Post
NCCN Releases New Guideline for Patients and Caregivers: Older Adults With Cancer
“NCCN Releases New Guideline for Patients and Caregivers: Older Adults With Cancer”
- 3 Sept 2026
The ASCO Post
The 2026 ASCO Annual Meeting Geriatric Oncology Update: The Next Challenge Is Implementation
“The 2026 ASCO Annual Meeting Geriatric Oncology Update: The Next Challenge Is Implementation”
This name entered the record from tracked coverage, not from an editor: the counts above are the evidence it was promoted on. No momentum read and no market price are shown because neither has been measured for it yet. Informational only — not advice. As of 2026-10-04 · live snapshot.